Many small molecular reagents target DNA-PK by inhibiting NHEJ repair, decrease the DNA damage-repair ability after radio-chemotherapy, increase sensitivity to radio-chemotherapy and achieve the purpose of the tumor treatments. Here, PRKDC is linked to neoplasm.